SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-311415
Filing Date
2017-10-17
Accepted
2017-10-17 09:23:02
Documents
1
Group Members
SOFTBANK VISION FUND L.P.SVF GP (JERSEY) LTDSVF HOLDINGS (UK) LLP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d474733dsc13da.htm SC 13D/A 87089
  Complete submission text file 0001193125-17-311415.txt   88821
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85963 | Film No.: 171140018
SIC: 2834 Pharmaceutical Preparations

Mailing Address 69 GROSVENOR STREET LONDON X0 W1K3JP
Business Address 69 GROSVENOR STREET LONDON X0 W1K3JP 6508435214
SVF Investments (UK) Ltd (Filed by) CIK: 0001716729 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A